180 Life Sciences Corp (ATNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
Operating Expenses | 138 | 121 | 141 | 50 | 31 |
Operating Income | -138 | -121 | -141 | -50 | -31 |
Other Income | 388 | 273 | 334 | 56 | 0 |
Pre-tax Income | 250 | 152 | 193 | 5 | -31 |
Income Tax | 76 | 88 | 107 | N/A | N/A |
Net Income Continuous | 174 | 64 | 86 | 5 | -31 |
Net Income | $174 | $64 | $86 | $5 | $-31 |
EPS Basic Total Ops | 15.21 | 11.41 | 7.60 | 0.00 | -3.80 |
EPS Basic Continuous Ops | 15.68 | 9.92 | 7.76 | 0.71 | -4.75 |
EPS Diluted Total Ops | 3.80 | 3.80 | 3.80 | 0.00 | -3.80 |
EPS Diluted Continuous Ops | 4.43 | 7.16 | 2.20 | 0.38 | -4.75 |
EBITDA(a) | $-138 | $-121 | $-141 | $-50 | $-31 |